Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.

Ansari AA, Park I, Kim I, Park S, Ahn SM, Lee JL

Open source

DOI
10.1186/s12920-018-0406-2
Published
2018 Oct 3
Container
BMC medical genomics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12920-018-0406-2,
  title = {Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.},
  author = {Ansari AA and Park I and Kim I and Park S and Ahn SM and Lee JL},
  year = {2018},
  journal = {BMC medical genomics},
  doi = {10.1186/s12920-018-0406-2},
  url = {https://doi.org/10.1186/s12920-018-0406-2}
}

RIS

TY  - JOUR
TI  - Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.
AU  - Ansari AA
AU  - Park I
AU  - Kim I
AU  - Park S
AU  - Ahn SM
AU  - Lee JL
PY  - 2018
JO  - BMC medical genomics
DO  - 10.1186/s12920-018-0406-2
UR  - https://doi.org/10.1186/s12920-018-0406-2
ER  - 

APA

AA, A., I, P., I, K., S, P., SM, A., & JL, L. (2018). Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.. BMC medical genomics. https://doi.org/10.1186/s12920-018-0406-2

Source records